ロード中...
Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design
Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by ataxia of all four limbs, dysarthria and arreflexia. A variety of measures are currently used to quantify disease progression, including the Friedreich Ataxia Rating Scale, examiner-rated functional disability sc...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2954653/ https://ncbi.nlm.nih.gov/pubmed/20063431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.22912 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|